Hairy Cell Leukemia Global Clinical Trials Review, H2, 2017

Price :
Published : Aug-2017
No. of Pages : 123

Hairy Cell Leukemia Global Clinical Trials Review, H2, 2017


GlobalData’s clinical trial report, “Hairy Cell Leukemia Global Clinical Trials Review, H2, 2017” provides an overview of Hairy Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hairy Cell Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

PDL BioPharma Inc (PDLI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions and non-dilutive growth capital to late-stage public and private healthcare companies. PDL provides companies, academic institutions, and inventors with an immediate financial monetization of royalty streams for acquiring new income generating assets. The company also carries out the humanization of monoclonal antibodies for facilitating the discovery of targeted treatments for cancer and other immunologic diseases. PDL is headquartered in Incline Village, Nevada, the US. PDL BioPharma Inc (P......

Endo International Plc (ENDP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies including Endo Pharmaceuticals, Paladin Labs, Par Pharmaceutical, Litha and SOMAR. It sells generic products principally in the US across multiple therapeutic categories, comprising urology, pain management, central nervous system (CNS) disorders, immunosuppression, cancer, cardiovascular diseases and women's health markets, among others. The company's branded pharmaceuticals target urology, orthopedics/pediatric endocrinology and pain management markets. Endo also provides over-the-counter (OTC) products across key market segments comprising dermatology and......

Medidata Solutions Inc (MDSO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data & analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data analytics solutions, using secure cloud and hybrid cloud infrastructure. Medidata's service portfolio includes implementation, configuration, data testing, and integration support, training, reporting and consultation services for clinical development process. The company offers its services to pharmaceutical, biotechnology and medical device companies, academic institutions, and contract research organizations. The company markets and sells its products through direct sales force, contract research......

Interleukin Genetics Inc (ILIU) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Interleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include ILUSTRA genetic risk test ; cardiovascular risk test; weight management genetic test; bone health genetic test; heart health genetic test; nutritional needs genetic test; and wellness select genetic test. ILUSTRA genetic test analyzes genetic variations associated with inflammation and helps in identifying individuals who are at increased risk for severe periodontal disease. The company distributes its products through partnership with healthcare professionals, health and wellness companies, and distribution channels. Interleukin is headquartered in Waltham, Massachusetts, the US. Interleukin Gen......

Sandoz Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Sandoz Inc (Sandoz), a division of Novartis AG, is a generic pharmaceutical company that develops, manufactures and distributes and sells a range of prescription medicines and protein and biotechnology-based products known as biosimilars. The company also provides intermediary products including active pharmaceutical ingredients (APIs), as well as biotechnology manufacturing services to other companies. It provides active ingredients and finished dosage forms of pharmaceuticals in the areas of dermatology, cancer, cardiovascular, respiratory, metabolism, central nervous system (CNS), pain, ophthalmic, gastrointestinal and hormonal therapies. Sandoz distributes its products to wholesalers, pharmacies, hospitals and other healthcare outlets. Sandoz is headquartered in Princeton, New......

Ligand Pharmaceuticals Inc (LGND) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Ligand Pharmaceuticals Inc (Ligand) develops and acquires technologies that help in discovery and development of medicines. The company provides a diversified portfolio of biotechnology and pharmaceutical products. Its marketed product portfolio encompasses indication for fungal infections, hepatitis C, Idiopathic thrombocytopenic purpura (ITP), multiple myeloma, cancer, osteoporosis, and severe aplastic anemia. Ligand's clinical development portfolio comprises medications targeted at the treatment of seizure, cancer, diabetes, coma, cardiovascular disease, liver disease, muscle wasting, kidney disease, and others. In partnership with other pharmaceutical companies the company also offers late-stage development, regulatory management and commercialization support. Ligand is headqu......

Amedisys Inc (AMED) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Amedisys Inc (Amedisys) is a healthcare company that offers home health care, hospice service and personal care. The company provides practical nursing services and occupational therapy, comfort and support services for those are facing a terminal illness. It also provides speech pathology, social services for acute and chronic illnesses, private duty services and home health aide services. The company operates a network of medicare-certified home health care centers, and medicare-certified hospice care centers which cover across several states in the US and the District of Columbia. Amedisys is headquartered in Baton Rouge, Louisiana, the US. Amedisys Inc (AMED) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the......

Bayer AG (BAYN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products in the areas of human and animal health care, and agriculture. It provides pharmaceuticals for cardiology, women's healthcare, oncology, hematology, ophthalmology, infection and other indications. The company's product portfolio includes prescription products, specialty therapeutics, animal health care products, diagnostic imaging equipment, nonprescription (over-the-counter - OTC) products, seeds, crop protection solutions, nonagricultural pest control solutions, and high-tech polymer materials. Bayer markets its healthcare and crop protection products principally through wholesalers, pharmacies, hospitals and retailers. It operates through a network of subsidiaries in Asia-Pacifi......

Alnylam Pharmaceuticals Inc (ALNY) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Alnylam Pharmaceuticals Inc, (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines; cardiovascular and metabolic disease; and hepatic infectious disease. It also offers Alnylam 5x15 program for advancing genetically defined disease targets for the treatment of respiratory syncytial virus and liver cancer. Alnylam employs lipid nanoparticles for intravenous systemic delivery of sRNAi to right body organs and cells so that it could trigger the RNAi mechanism. The company works in partnership with Merck, Medtronic, Roche, Novartis, Biogen, Takeda, Cubist, GlaxoSmithKline, Ascletis, The M......

Bristol-Myers Squibb Co (BMY) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and virology (including hepatitis B, hepatitis C and HIV infection) therapeutic classes. The company offers its products across the world primarily to retail pharmacies, wholesalers, hospitals, medical professionals and government entities. BMS provides its products in the US, Europe, Japan and other countries. The company's research activities focus on the discovery and development of novel medicines that address serious disease in areas of significant unmet medical need. BMS is headquartered in N......